Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-446-6 | CAS number: 106-95-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no deviations from standard test guidelines and no methodological deficiences, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- Freund's complete adjuvant test
Test material
- Reference substance name:
- 3-bromopropene
- EC Number:
- 203-446-6
- EC Name:
- 3-bromopropene
- Cas Number:
- 106-95-6
- Molecular formula:
- C3H5Br
- IUPAC Name:
- 3-bromoprop-1-ene
- Reference substance name:
- 1-bromoprop-2-ene
- IUPAC Name:
- 1-bromoprop-2-ene
- Details on test material:
- Description: colourless liquid
Container: one smoked glass flask
Storage conditions: at room tempertaure and protected from light
Purity: 99.5%
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Number: 30 animals (15 males and 15 nulliparous and non-pregnant females)
Allocation of the animals to the groups: on day-1, the animals were weighted and randomly allocated to two groups. A control group 1 consisting of ten animals (five males and 5 females) and a treated group 2 consisting of 20 animals (ten males and ten females).
Weight: on day-1, the animals were approximatively three months old and had a mean body weight ± standard deviation of 306±19 g for the males and 309±22 g for the females.
Acclimatization: at least five days before the beginning of the study.
Identification of the animals: ear-tattoo.
During the acclimatization period and troughout the study, the conditions in the animal room were set as follows:
- temperature: 21±2°C
- relative humidity: 30 to 70%
- light/dark cycle: 12h/12h
- ventilation: about 12 cycles/hour of filtered, non-recycled air.
The temperature and relative humidity were recorded continuously and records retained.
The housing conditions were checked regularly.
During the acclimatization period and throughout the study, the animals were housed individually in polycarbonate cages (48x27x20 cm) equipped with a polypropylene bottle.
Dust-free sawdust was provided as litter.
Bacteriological analysis of the sawdust and detection of possible contaminants were performed periodically.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- paraffin oil
- Concentration / amount:
- A preliminary test was conducted in order to determine the concentrations to be tested in the main study.
By intradermal route:
- 24 hours before treatment, the dorsal region of the animals were clipped,
- the test substance was prepared in an appropriate vehicule,
- intradermal administartions of the test substance (0.1 mL) at different concentrations were performed in the dorsal region between the shoulders,
- cutaneaous reactions were evaluated approximately 24, 48 hours and six days after injection.
By cutaneous route:
- 24 hours before treatment, both flank regions of the animals were clipped,
- if necessary, the test substance was prepared in an appropriate vehicule,
- the test substance (0.5 mL for each concentration) was applied to a dry gauze pad of approximately 4 cm2 which was held in place by an occlusive dressing for 24 hours,
- cutaneaous reactions were evaluated approximately 24, 48 hours after removal of the dressing.
Criteria for selection of concentrations
The following criteria were used:
- the concentrations should be well-tolerated systemically and locally,
- intradermal injections should cause moderate irritant effect (no necrosis or ulceration of the skin),
- topical application for the induction should cause at most weak or moderate skin reactions or be the maximal practicable concentration,
- topical application for the challenge should be the highest concentration which does not cause irritant effect.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- A preliminary test was conducted in order to determine the concentrations to be tested in the main study.
By intradermal route:
- 24 hours before treatment, the dorsal region of the animals were clipped,
- the test substance was prepared in an appropriate vehicule,
- intradermal administartions of the test substance (0.1 mL) at different concentrations were performed in the dorsal region between the shoulders,
- cutaneaous reactions were evaluated approximately 24, 48 hours and six days after injection.
By cutaneous route:
- 24 hours before treatment, both flank regions of the animals were clipped,
- if necessary, the test substance was prepared in an appropriate vehicule,
- the test substance (0.5 mL for each concentration) was applied to a dry gauze pad of approximately 4 cm2 which was held in place by an occlusive dressing for 24 hours,
- cutaneaous reactions were evaluated approximately 24, 48 hours after removal of the dressing.
Criteria for selection of concentrations
The following criteria were used:
- the concentrations should be well-tolerated systemically and locally,
- intradermal injections should cause moderate irritant effect (no necrosis or ulceration of the skin),
- topical application for the induction should cause at most weak or moderate skin reactions or be the maximal practicable concentration,
- topical application for the challenge should be the highest concentration which does not cause irritant effect.
- No. of animals per dose:
- A control group 1 consisting of ten animals (five males and 5 females) and a treated group 2 consisting of 20 animals (ten males and ten females).
- Details on study design:
- Preparation of the animals
For all animals and before each treatment, the applications sites were:
- clipped on days 1 and 7 (scapular area 4x2 cm),
- clipped and shaved on day 21 (each flank 2x2 cm),
- clipped again on day 25 (each flank 2x2 cm).
Intradermal route
On day 1, six injections wera made deep into the dermis of a clipped area (4x2 cm) in the dorsal region between the shoulders, using a needle mounted on a 1 mL glass syringe.
Three injections of 0.1 mL were made into each side of this shoulder region, as follows:
Injection sites* Treated group Control group
Anterior 1: FCA diluted at 50% (v/v) 1: FCA diluted at 50% (v/v)
with 0.9% NaCl with 0.9% NaCl
Middle 2: test substance at 0.5% (w/w) 2: vehicule
in paraffin oil
Posterior mixture of 50/50 (w/v) mixture of 505/50 (w/v)
of 1 and 2 of 1 and 2
*: three pairs of sites
FCA: Freund's complete adjuvant
Cutaneous route
As the test substance was shown to be irritant during the preliminary tests, a topical application with sodium laurylsulphate was not necessary on day 7.
On day 8, a topical application to the region of the intradermal injections (4x2 cm) was performed.
Control group : application of 0.5 mL of the vehicle.
Treated group: application of 0.5 mL of teh test substance at the chosen concentrations.
The test substance and the vehicle were prepared on a dry gauze pad which was then applied to the dorsal region between the shoulders and held in place for 48 hours by means of an adhesive hypoallergenic dressing and an adhesive anallergenic waterproof plaster.
On removal of the dressing, if present, any residual test substance was removed by means of a dry or a moistened gauze pad.
Cutaneous reactions were recorded one hour after removal of the occlusive dressing.
Challenge phase
On day 22, the animals from both groups received an application of 0.5 mL of the test substance at the chosen concentration to the posterior right flank, and 0.5 mL of the vehicle to the posterior left flank.
This application was performed using a 1 mL plastic syringe.
The test substance and the vehicle were prepared on a dry gauze pad, then applied to a 4 cm2 (2x2 cm) clipped area of the skin. The gauze pad was held in contact with the skin for 24 hous by means of an occlusive, hypoallergenic dressing and an adhesive anallergenic waterproof plaster.
On removal of the dressing, if present, any residual test substance was removed by means of a dry or a mointened gauze pad. - Positive control substance(s):
- not required
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.5 mL at a concentration of 1% (w/w)
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- Very slight erythema (barely perceptible)
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.5 mL at a concentration of 1% (w/w). No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Very slight erythema (barely perceptible).
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.5 mL at a concentration of 1% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- Dryness of the skin for 7 animals (5 males and 2 females)
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5 mL at a concentration of 1% (w/w). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: Dryness of the skin for 7 animals (5 males and 2 females).
Any other information on results incl. tables
No clinical signs and no mortalities were observed during the study.
The body weight gain of the tretad animals was normal when compared to that of the control animals.
Challenge application : no residual test substance was observed after removal of the dressing.
Comparable very weak skin reactions were observed in both groups, they were attributed to a slight irritant effect of the test substance.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under experimental conditions and according to the maximization method of Magnusson and Kligman, no cutaneous reactions attributable to the sensitization potential of allyl bromide at a concentration of 1% (w/w) were observed un guinea-pigs.
Therefore, allyl bromide should not be considered as sensitizing.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.